Presentation, Treatment, and Outcomes of Haitian Women With Breast Cancer in Miami and Haiti: Disparities in Breast Cancer—A Retrospective Cohort Study
Authors:
Open Access
- 1 August 2017
- journal article
- research article
- Published by American Society of Clinical Oncology (ASCO) in Journal of Global Oncology
- Vol. 3 (4) , 389-399
Abstract
Purpose: We compared a cohort of Haitian immigrants with residents in Haiti with breast cancer (BC) to evaluate the effects of location on presentation, treatment, and outcomes.Patients and Methods: Participants were Haitian women with BC living in Miami who presented to the University of Miami/Jackson Memorial Hospital and women with BC living in Haiti who presented to the Innovating Health International Women’s Cancer Center. The primary outcome was the relationship between location, cancer characteristics, and survival. The secondary objective was to compare our results with data extracted from the SEER database. Cox regression was used to compare survival.Results: One hundred two patients from University of Miami/Jackson Memorial Hospital and 94 patients from Innovating Health International were included. The patients in Haiti, compared with the patients in Miami, were younger (mean age, 50.2 v 53.7 years, respectively; P = .042), presented after a longer duration of symptoms (median, 20 v 3 months, respectively; P < .001), had more advanced stage (44.7% v 25.5% with stage III and 27.6% v 18.6% with stage IV BC, respectively), and had more estrogen receptor (ER) –negative tumors (44.9% v 26.5%, respectively; P = .024). The percentage of women who died was 31.9% in Haiti died compared with 17.6% in Miami. Median survival time was 53.7 months for women in Haiti and was not reached in Miami. The risk of death was higher for women in Haiti versus women in Miami (adjusted hazard ratio, 3.09; P = .0024).Conclusion: Women with BC in Haiti experience a significantly worse outcome than immigrants in Miami, which seems to be related to a more advanced stage and younger age at diagnosis, more ER-negative tumors, and lack of timely effective treatments. The differences in age and ER status are not a result of access to care and are unexplained.Keywords
This publication has 21 references indexed in Scilit:
- Determinants of Breast Cancer Treatment Delay Differ for African American and White WomenCancer Epidemiology, Biomarkers & Prevention, 2013
- Breast cancer survival in women of African descent living in the US and in the Caribbean: effect of place of birthBreast Cancer Research and Treatment, 2010
- Community-Based Participatory Research in Little Haiti: Challenges and Lessons LearnedProgress in Community Health Partnerships: Research, Education, and Action, 2009
- The categorization of African descent populations in Europe and the USA: should lexicons of recommended terminology be evidence-based?Public Health, 2008
- Breast Cancer among Immigrants: A Systematic Review and New Research DirectionsJournal of Immigrant and Minority Health, 2007
- Delays in Breast Cancer Diagnosis and Treatment by Racial/Ethnic GroupArchives of internal medicine (1960), 2006
- Migration History, Acculturation, and Breast Cancer Risk in Hispanic WomenCancer Epidemiology, Biomarkers & Prevention, 2005
- Negro, Black, Black African, African Caribbean, African American or what? Labelling African origin populations in the health arena in the 21st century: Table 1Journal of Epidemiology and Community Health, 2005
- Paradigm lost: race, ethnicity, and the search for a new population taxonomyAmerican Journal of Public Health, 2001
- A Proportional Hazards Model for the Subdistribution of a Competing RiskJournal of the American Statistical Association, 1999